Last reviewed · How we verify
Multimodal Intravenous Analgesia
At a glance
| Generic name | Multimodal Intravenous Analgesia |
|---|---|
| Sponsor | Udayana University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intravenous Lidocaine Infusion in Lumbar Fusion Surgery (NA)
- ERAS (Enhanced Recovery After Surgery) and Multimodal Analgesia in Laparoscopic Cholecystectomy
- Post-Hoc Cost-Utility Analysis of Ultrasound-Guided Erector Spinae Plane (ESP) Block Versus Total Intravenous Anesthesia (TIVA) in Posterior Scoliosis Correction Surgery: Evidence From the Egyptian EQ-5D-5L Value Set
- Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults (NA)
- Postoperative Pain and Analgesic Use After Total Knee Arthroplasty
- FRONT Block for Quality of Recovery After Total Hip Arthroplasty (NA)
- Postoperative Pain Monitoring With ANI in Lumbar Spine Surgery (NA)
- Oral vs Intravenous Dexamethasone in Total Knee Arthroplasty
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Multimodal Intravenous Analgesia CI brief — competitive landscape report
- Multimodal Intravenous Analgesia updates RSS · CI watch RSS
- Udayana University portfolio CI